Arthur T. Sands

2023 - Nurix Therapeutics

In 2023, Arthur T. Sands earned a total compensation of $4.4M as President, Chief Executive Officer and Director at Nurix Therapeutics, a 54% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$355,350
Option Awards$3,376,799
Salary$590,813
Other$40,158
Total$4,363,120

Sands received $3.4M in option awards, accounting for 77% of the total pay in 2023.

Sands also received $355.4K in non-equity incentive plan, $590.8K in salary and $40.2K in other compensation.

Rankings

In 2023, Arthur T. Sands' compensation ranked 76th out of 1,352 executives tracked by ExecPay. In other words, Sands earned more than 94.4% of executives.

ClassificationRankingPercentile
All
76
out of 1,352
94th
Division
Manufacturing
40
out of 666
94th
Major group
Chemicals And Allied Products
19
out of 320
94th
Industry group
Drugs
19
out of 296
94th
Industry
Pharmaceutical Preparations
13
out of 223
94th
Source: SEC filing on March 27, 2024.

Sands' colleagues

We found two more compensation records of executives who worked with Arthur T. Sands at Nurix Therapeutics in 2023.

2023

Gwenn Hansen

Nurix Therapeutics

Chief Scientific Officer

2023

Hans van Houte

Nurix Therapeutics

Chief Financial Officer

News

In-depth

You may also like